首页
订购/客服:400-666-5481

SX-682

    
10mM in DMSO

SX-682

源叶(MedMol)
T96349 一键复制产品信息
1648843-04-2
C19H14BF4N3O4S
467.2
Boronic acid,B-​[2-​[[[5-​[[(4-​fluorophenyl)​amino]​carbonyl]​-​2-​pyrimidinyl]​thio]​methyl]​-​4-​(trifluoromethoxy)​phenyl]​-
货号 规格 价格 上海 北京 珠海 重庆 武汉 购买数量
T96349-1ml促销
10mM in DMSO

¥720.00 ¥648.00

3 - - - -
产品介绍 参考文献 质检证书(COA) 摩尔浓度计算器 相关产品
产品描述: CXCR 抑制剂;CXCR Inhibitors;;InformationSX-682 SX-682 is an orally bioavailable small-molecule allosteric inhibitor of CXCR1 and CXCR2 that blocks tumor MDSC recruitment and enhances T cell activation and antitumor immunity.TargetsCXCR1 ; CXCR2In vivoWhole tumor accumulation of CXCL1 in vivo in MOC1 and LLC tumors is significantly greater than oral mucosa and normal lung, respectively, and not diminished with SX-682 treatment. Plasma accumulation of CXCL1 is greater in tumor-bearing mice compared with naive for both models and increases following SX-682 treatment. Treatment of mice bearing MOC1 or LLC tumors with SX-682 beginning 10 or 20 days after tumor initiation does not alter CXCR1 or CXCR2 expression on tumor cells in vivo.[2] Following in vivo SX-682 treatment, tumor PMN-MDSC expression of cell surface TGF-β or superoxide dismutase 1/2 genes, responsible for the generation of H2O2, is not significantly altered.[3]
体内研究: SX-682 (50 mg/kg;口服;周一至周五;每天两次) 观察到作为单一药物对 CRPC 进展的影响微弱至中等,但与 ICB 联合产生了强大的效果。
参考文献: 1. Sun L, et al. Inhibiting myeloid-derived suppressor cell trafficking enhances T cell immunotherapy. JCI Insight. 2019 Apr 4;4(7).
2. Lu X, et al. Effective combinatorial immunotherapy for castration-resistant prostate cancer. Nature. 2017 Mar 30;543(7647):728-732.
保存条件: -80℃(运输条件:冰袋低温运输)
配置溶液浓度参考:
1mg 5mg 10mg
1 mM 2.14 ml 10.702 ml 21.404 ml
5 mM 0.428 ml 2.14 ml 4.281 ml
10 mM 0.214 ml 1.07 ml 2.14 ml
50 mM 0.043 ml 0.214 ml 0.428 ml
注意: 部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。

参考文献

质检证书(COA)

如何获取质检证书(COA)?
请输入货号和一个与之匹配的批号。
例如:
批号:JS298415 货号:S20001-25g
在货品标签上如何找到货号和批号?

摩尔浓度计算器

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)

=
×
×